Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
07/12/2007 | US20070161792 Methods for preparing 2,3,5,6-substituted 3h-pyrimidin-4-ones |
07/12/2007 | US20070161651 Tie-2 modulators and methods of use |
07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
07/12/2007 | US20070161637 Substituted pyridin-2-ylamine analogues |
07/12/2007 | US20070161622 Diamino alcohols and their use as renin inhibitor |
07/12/2007 | CA2635580A1 Substituted bis-amide metalloprotease inhibitors |
07/11/2007 | EP1805155A1 Thrombopoietin activity modulating compounds and methods |
07/11/2007 | EP1805148A2 Crystalline rosuvastatin intermediate |
07/11/2007 | CN1997643A Heterocyclic compounds and their use as aldosterone synthase inhibitors |
07/11/2007 | CN1997640A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
07/11/2007 | CN1997622A Polycationic compounds and uses thereof |
07/11/2007 | CN1997619A Phenyl derivatives comprising an acetylene group |
07/11/2007 | CN1995022A Process for the synthesis of nucleoside analogues |
07/11/2007 | CN1325480C Novel phenylalanine derivatives |
07/11/2007 | CN1325479C Pyrimidine compounds |
07/11/2007 | CN1325456C Perfluoroallyloxy compound and liquid-crystal composition containing the compound |
07/10/2007 | US7241889 2-Amino-5-formyl-substituted, e.g., 2-[p-(cyclopropylaminocarbonyl)phenyl]-5-formyl-8-isopentyl--7-methyl-5,6,7,8-tetrahydropteridine; antiproliferative agents |
07/10/2007 | US7241883 Functionalized compositions for improved immobilization |
07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
07/10/2007 | US7241769 Pyrimidines as PLK inhibitors |
07/10/2007 | US7241767 And thiones, 1-substituted with a pyrazolyl(thio)carbonyl group, e.g., 6-Bromo-1-[[3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]carbonyl]-8-methyl-3-(1-methylethyl)-2,4(1H,3R)-quinazolinedione; especially for use in growing and stored agronomic crops |
07/10/2007 | US7241765 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
07/10/2007 | US7241721 carboxamide derivatives as active ingredients which have microbiocidal activity, in particular fungicidal activity |
07/10/2007 | US7241458 Antiviral compositions |
07/05/2007 | WO2007076247A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
07/05/2007 | WO2007076092A2 Nitrogen- containing bicyclic hetroaryl compounds for the treatment of raf protein kinase-mediated diseases |
07/05/2007 | WO2007075194A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
07/05/2007 | WO2007074789A1 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof |
07/05/2007 | WO2007074391A2 Preparation of a key intermediate in the synthesis of rosuvastatin |
07/05/2007 | WO2007058583A3 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
07/05/2007 | WO2007043094A3 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof |
07/05/2007 | US20070155959 Protease inhibitor conjugates and antibodies useful in immunoassay |
07/05/2007 | US20070155839 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene) methyl]benzoic acid; selective estrogen receptor modulation; SERMS |
07/05/2007 | US20070155777 Antiinflammation agents |
07/05/2007 | US20070155765 Method of preparation of the hemi-calcium salt of (e)-7-[4-(4fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonvl)aminolpyrimidin-5-yl](3r,5s)-3,5-, dihvdroxy-6-heptenoic acid |
07/05/2007 | US20070155763 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the phophylaxis and treatment of disorders related thereto |
07/05/2007 | US20070155762 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase |
07/05/2007 | US20070155760 Adenosine A2a receptors antagonist; 9H-indeno[2,1-c]pyridine-4-carboxylic acid, 3-amino-1-furan-2-yl-9-oxo-, 2-dimethylamino-ethyl ester; neurodegenerative and movement disease, as Parkinson's; improves binding affinity of Dopamine D2 agonist to their receptors |
07/05/2007 | US20070155757 Use of pyrimidine compounds in the preparation of parasiticides |
07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
07/05/2007 | US20070155748 N-sulfonyl-alpha-amino-acid derivatives |
07/05/2007 | US20070155719 Platelet ADP receptor inhibitors |
07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
07/05/2007 | US20070154972 immunogens, monoclonal antibodies which bind selectively to 5-fluoro-uracil and have cross-reactivity with uracil, cytosine and tegafur; for rapidly determining optimal drug concentrations during chemotherapy |
07/05/2007 | CA2642130A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
07/05/2007 | CA2634768A1 3-aryl-substituted quinazolones, and uses thereof |
07/05/2007 | CA2633992A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
07/05/2007 | CA2633653A1 Heterocyclic derivatives as modulators of ion channels |
07/04/2007 | EP1803710A1 Pyrimidine derivative condensed with non-aromatic ring |
07/04/2007 | EP1802591A1 Quinazoline derivatives |
07/04/2007 | EP1802590A1 Substituted n-alkylpyrimidinones |
07/04/2007 | EP1802589A1 Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6h)-yl]-n-(2-hydroxyethyl)-4-methylbenzamide |
07/04/2007 | EP1802588A1 Substituted amino-pyrimidones and uses thereof |
07/04/2007 | EP1802587A1 Substituted amino-compounds and uses thereof |
07/04/2007 | EP1802586A2 Heteroaryl-substituted alkyne compounds and method of use |
07/04/2007 | EP1644343B1 5-substituted quinazolinone derivatives |
07/04/2007 | EP1484971B1 Use of 4-aminopyrimidines for the antimicrobial treatment of surfaces |
07/04/2007 | EP0977750B1 Farnesyltransferase inhibiting quinazolinones |
07/04/2007 | CN1993356A Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
07/04/2007 | CN1990477A Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
07/04/2007 | CN1989969A Cyclic protein tyrosine kinase inhibitors |
07/04/2007 | CN1324034C Dioxazole pyrimidine nucleotide compounds with function of releasing NO and its use in pharmaceutics |
07/04/2007 | CN1324030C Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances |
07/04/2007 | CN1324015C Pyridine and pyrimidine derivatives |
07/03/2007 | US7238807 Hydrogenating a nitropyrimidine derivative with hydrogen in the presence of a hydrogenation catalyst, adding a copper, iron or vanadium compound to produce 7,8-dihydro-5H-pteridin-6-one derivatives |
07/03/2007 | US7238724 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
07/03/2007 | US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
07/03/2007 | US7238702 Dihydroquinazolinones as 5HT modulators |
07/03/2007 | US7238701 Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders |
07/03/2007 | US7238698 2-amino-6-phenoxy-substituted quinazoline derivatives; treating arthritis, Crohn's disease, Alzeihmer's disease, adult respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, stroke, sepsis, myocardial infarction, and spondylitis. |
07/03/2007 | US7238693 Gastrointestinal disorders; central nervous system disorders; cardiovascular disorders |
07/03/2007 | US7238684 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
07/03/2007 | CA2397258C Preparation of sulfonamides |
06/28/2007 | WO2007073284A1 SUBSTITUTED 2-AMINOPYRIMIDINE-4-ONES, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF Aß-RELATED PATHOLOGIES |
06/28/2007 | WO2007073117A1 Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
06/28/2007 | WO2007071963A2 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents |
06/28/2007 | WO2007071900A1 Novel herbicides |
06/28/2007 | WO2007071752A2 Pyrimidinyl aryl urea derivatives being fgf inhibitors |
06/28/2007 | WO2007071455A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
06/28/2007 | WO2007071358A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
06/28/2007 | WO2007071199A1 2,4-disubstituted amido-6-substituted-[1,3,5]triazine or 1,3-pyrimidine compounds, their processes for preparation, their pharmaceutical compositions and uses thereof |
06/28/2007 | WO2007071055A1 Compositions and methods for modulating gated ion channels |
06/28/2007 | WO2007048065A3 Pyrimidinones as casein kinase ii (ck2) modulators |
06/28/2007 | WO2007041666B1 Preparation of rosuvastatin |
06/28/2007 | WO2007026920A3 Amide derivatives as rock inhibitors |
06/28/2007 | WO2007016355A3 Process for the synthesis of progesterone receptor modulators |
06/28/2007 | US20070149779 Primidone process and compositions |
06/28/2007 | US20070149565 Nelfinavir conjugates and antibodies useful in immunoassay |
06/28/2007 | US20070149551 crop protection agents for controlling harmful fungi; improved activity; [6-chloro-2-(N'-isopropylidene-hydrazino)-5-(2,4,6-trifluorophenyl)pyrimidine-4-yl]-((S)-1-tri-fluoromethylethyl)amine; against Septoria Leaf Blotch of Wheat, Net Blotch of Barley and Mildew of Cucumber |
06/28/2007 | US20070149546 4-Anilino-quinazoline derivatives as antiproliferative agents |
06/28/2007 | US20070149510 Quinazolinone and benzoxazinone derivatives and uses thereof |
06/28/2007 | US20070149500 Compounds, compositions, and methods |
06/28/2007 | US20070148708 Protease inhibitor conjugates and antibodies useful in immunoassay |
06/28/2007 | DE102005062742A1 Sulfoximin substituierte Pyrimidine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel Sulfoximine substituted pyrimidines, process for their preparation and their use as medicaments |
06/28/2007 | DE102005062175A1 Detergent- or cleaning agent, useful e.g. in liquid or gel form for flushing toilets and hard surface cleaning, comprises cyclic aminal |
06/28/2007 | CA2634636A1 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
06/28/2007 | CA2634491A1 Compositions and methods for modulating gated ion channels |
06/28/2007 | CA2634047A1 Pyrimidinyl aryl urea derivatives being fgf inhibitors |